Connor A Ott

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Molecular Dynamics Simulations

Subarachnoid Hemorrhage

Signaling Pathway

Top Venues

Nature communications

Molecular cancer research : MCR

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sheera R Rosenbaum, Signe Caksa, Casey D Stefanski, Isabella V Trachtenberg, Haley P Wilson, Nicole A Wilski, Connor A Ott, Timothy J Purwin, Jelan I Haj, Danielle Pomante, Daniel Kotas, Inna Chervoneva, Claudia Capparelli, Andrew E Aplin
SOX10 loss sensitizes melanoma cells to cytokine-mediated inflammatory cell death. Molecular cancer research : MCR (2023)
McKenna Q Glasheen, Signe Caksa, Amelia G Young, Nicole A Wilski, Connor A Ott, Inna Chervoneva, Keith T Flaherty, Meenhard Herylyn, George X Xu, Andrew E Aplin, Claudia Capparelli
Targeting up-regulated cIAP2 in SOX10-deficient drug tolerant melanoma. Molecular cancer therapeutics (2023)
Tyler J Florio, Ravi K Lokareddy, Daniel P Yeggoni, Rajeshwer S Sankhala, Connor A Ott, Richard E Gillilan, Gino Cingolani
Differential recognition of canonical NF-κB dimers by Importin α3. Nature communications 13 (1) (2022)
Luca Pagliaroli, Patrizia Porazzi, Alyxandra T Curtis, Chiara Scopa, Harald M M Mikkers, Christian Freund, Lucia Daxinger, Sandra Deliard, Sarah A Welsh, Sarah Offley, Connor A Ott, Bruno Calabretta, Samantha A Brugmann, Gijs W E Santen, Marco Trizzino
Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders. Nature communications 12 (1) (2021)